Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,758 Jan 1 – Oct 26, 2026
- Disclosed funding
- $346.8B 3695 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SE Scholar EducationCompany profile Scholar Education builds AI tools for special-education teams and students, covering evaluation, classroom accommodations and progress monitoring. Scholar Education builds AI tools for special-education teams and students, covering evaluation, classroom accommodations and progress monitoring. | $2M | Seed | Edtech | United States | Investors | |
| AI AIONA, Inc.Company profile AI design agents that help manufacturing engineers apply technical documents and past design knowledge across product-development workflows. AI design agents that help manufacturing engineers apply technical documents and past design knowledge across product-development workflows. | ¥140M | J-KISS and loan financingUndisclosed | Industrial tech | Japan | Investors | |
| A AndoCompany profile Ando provides team messaging where people and AI agents share conversations and working context. Ando provides team messaging where people and AI agents share conversations and working context. | $20M | Combined pre-seed and seedUndisclosed | Enterprise software | United States | Investors | |
50skillsCompany profile Employee and candidate workflows connecting HR systems, automation and human review. Employee and candidate workflows connecting HR systems, automation and human review. | $6M | Funding roundUndisclosed | Enterprise software | Iceland | Investors | |
QambriaCompany profile Qambria builds software that connects quantum processors to high-performance computing systems, helping developers run hybrid quantum-classical workloads with low-latency control. Qambria builds software that connects quantum processors to high-performance computing systems, helping developers run hybrid quantum-classical workloads with low-latency control. | CHF 850K | Innosuisse grantUndisclosed | Enterprise software | Switzerland | Investors | |
| KT Kasvu TherapeuticsCompany profile Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs. Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs. | €30M | Series A | Biotech | Finland | Investors | |
Reply NextCompany profile Reply Next helps multi-location brands manage reviews, ratings, customer messages and local search presence across digital platforms from one workspace. Reply Next helps multi-location brands manage reviews, ratings, customer messages and local search presence across digital platforms from one workspace. | €400K | Pre-seed | AI | Spain | Investors | |
ClastixCompany profile Clastix builds Kubernetes infrastructure software, including Kamaji for hosted tenant control planes and kMetal for bare-metal cluster operations. Clastix builds Kubernetes infrastructure software, including Kamaji for hosted tenant control planes and kMetal for bare-metal cluster operations. | €2.9M | Seed | Developer tools | Italy | Investors | |
| AM Aligned Modern HealthCompany profile A physician-led care provider offering functional medicine, hormone health and related services through clinics and telehealth. A physician-led care provider offering functional medicine, hormone health and related services through clinics and telehealth. | Undisclosed | Majority growth investmentGrowth | Healthtech | United States | Investors | |
| UI United ImmunityCompany profile A biotechnology company developing nanoparticle delivery systems and immunotherapies that target macrophages and dendritic cells in diseased tissue. A biotechnology company developing nanoparticle delivery systems and immunotherapies that target macrophages and dendritic cells in diseased tissue. | ¥2.2B | Private financingUndisclosed | Biotech | Japan | Investors Aozora HYBRID Fund IIIFujita TT Impact Fund I +11ITOCHU CorporationJoyo Bank, Ltd.Kobe University Fund IMitsubishi UFJ Life Sciences Fund IIMiyako Kyoto University Innovation Fund IIIMizuho Life Sciences Fund INVCC Fund 10Ono Venture Investment, Inc.Ricoh Biomedical Startup Investment Limited PartnershipSaisei Bioventures L.P.UTEC Fund V Limited Partnership |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
112rounds22led - 3General Catalyst
Matiks, Provision Labs, Tractian
103rounds13led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Nevis, Warhound, Whop
73rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →